Simplex Trading’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.2K Sell
400
-5,500
-93% -$296K ﹤0.01% 6692
2025
Q4
$286K Buy
5,900
+2,100
+55% +$81.9K ﹤0.01% 3868
2025
Q3
$116K Sell
3,800
-13,300
-78% -$305K ﹤0.01% 5570
2025
Q2
$379K Buy
17,100
+6,500
+61% +$136K ﹤0.01% 3802
2025
Q1
$197K Sell
10,600
-59,100
-85% -$986K ﹤0.01% 4344
2024
Q4
$922K Buy
69,700
+63,800
+1,081% +$1.55M ﹤0.01% 2921
2024
Q3
$197K Buy
+5,900
New +$202K ﹤0.01% 4526
2024
Q1
Sell
-200
Closed -$4K 8770
2023
Q4
$4K Buy
+200
New +$3.45K ﹤0.01% 7929
2023
Q1
Sell
-200
Closed -$6K 8928
2022
Q4
$6K Sell
200
-15,000
-99% -$424K ﹤0.01% 7899
2022
Q3
$387K Buy
15,200
+200
+1% +$4.69K ﹤0.01% 3771
2022
Q2
$304K Buy
+15,000
New +$332K ﹤0.01% 4083
2021
Q4
Sell
-1,400
Closed -$36K 10395
2021
Q3
$36K Hold
1,400
﹤0.01% 7901
2021
Q2
$36K Buy
1,400
+1,372
+4,900% +$32.9K ﹤0.01% 8017
2021
Q1
$60K Sell
28
-8
-22% -$202 ﹤0.01% 6379
2020
Q4
$77K Buy
36
+31
+620% +$753 ﹤0.01% 5701
2020
Q3
$7K Sell
5
-51
-91% -$920 ﹤0.01% 6938
2020
Q2
$125K Sell
56
-345
-86% -$6.31K ﹤0.01% 4554
2020
Q1
$566K Sell
401
-129
-24% -$1.96K ﹤0.01% 2464
2019
Q4
$861K Buy
530
+499
+1,610% +$11.8K ﹤0.01% 2223
2019
Q3
$108K Buy
31
+26
+520% +$1.24K ﹤0.01% 4243
2019
Q2
$28K Buy
5
+3
+150% +$216 ﹤0.01% 5321
2019
Q1
$14K Buy
2
+1
+100% +$69 ﹤0.01% 5920
2018
Q4
$6K Sell
1
-452
-100% -$33.6K ﹤0.01% 6106
2018
Q3
$4.52M Buy
+453
New +$37.6K 0.01% 679
2018
Q2
Sell
-15
Closed -$27K 7314
2018
Q1
$27K Buy
+15
New +$1.69K ﹤0.01% 3042

Other funds holding ANAB

Simplex Trading's ANAB Position: Q4 2024 in Review

Simplex Trading sold out of AnaptysBio (ANAB) in Q4 2024, closing a stake of 3,423 shares — an estimated $82.9K sold.

Simplex Trading first reported a position in ANAB in Q1 2018 and held it in 13 quarters. The position peaked at $332K in Q1 2021. 135 funds tracked by Wall St. Rank hold ANAB as of Q4 2024.

  • Simplex Trading reported no remaining AnaptysBio position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 3,423 AnaptysBio shares in Q4 2024, an estimated $82.9K.
  • Simplex Trading first reported a position in AnaptysBio in Q1 2018 and held it in 13 quarters.
  • Simplex Trading's AnaptysBio position peaked at $332K in Q1 2021.
  • 135 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.